( HALO ) - Analyzing Halozyme Therapeutics's Short Interest - Halozyme Therapeutics ( NASDAQ:HALO )

2 months ago

Halozyme Therapeutics's HALO short percent of float has risen 3.77% since its last report. The company recently reported that it has 10.04 million shares sold short, which is 10.74% of all regular shares that are available for trading.

Ticker	Sentiment	Impact
HALO	Neutral	21 %